return to press releases

March 18, 2003

Dr. Ronald M. Lindsay Joins AnVil, Inc. Board of Directors

Pioneer in life sciences discovery adds longtime biotech executive and researcher to directorship.

Burlington, MA - March 18, 2003 - AnVil, Inc., a pioneer in life sciences discovery, today announced that Ronald M. Lindsay, Ph.D. has joined its Board of Directors.

Dr. Lindsay, a longtime biotech executive and entrepeneur who currently serves as Chief Scientific Officer and Vice President of R&D at diaDexus, Inc. of San Francisco, adds nearly 25 years of research and managerial experience to AnVil's board. In his career, Dr. Lindsay has managed all aspects of life science R&D from genomics and proteomics discovery and preclinical R&D, to moving product candidates into clinical trials. He has in-depth expertise in neuroscience, as well as recent experience in inflammation and cancer.

"We're honored to have a director with Dr. Lindsay's prominence and expertise on our Board," said Dr. Richard D. Gill, President and Chief Executive Officer of AnVil. "Dr. Lindsay's vast research experience, and his long record of bringing success to biotech, diagnostics and therapeutics firms, will prove an invaluable addition."

Prior to diaDexus, Dr. Lindsay served as Senior Vice President, Biotherapeutics, for Millennium Pharmaceuticals, Inc. in Cambridge, Massachusetts, where he was previously Vice President, R&D of the Millennium Biotherapeutics Inc subsidiary. For nearly a decade, Dr. Lindsay held the post of Vice President, Neurobiology for Tarrytown, New York-based Regeneron Pharmaceuticals, Inc.

Before embarking on his private sector biotech career, Dr. Lindsay was Head of Cell Biology at the Sandoz Institute for Medical Research, University College, London, in the UK. Prior to that, he held the post of Staff Scientist, Medical Research Council Lab, Neurobiology, at the National Institute of Medical Research, Mill Hill, London, UK.

About AnVil
AnVil is a pioneering life sciences discovery company that turns data into knowledge. AnVil partners with life sciences, pharmaceutical, biotechnology, and healthcare companies, enabling them to see and interpret multiple data sets in integrated, information-rich views. This approach turns data into decision-quality information, generating informed decisions faster and more accurately. AnVil's combination of scientific perspective, expertise and high-dimensional technology uncovers the limitless possibilities within complex data sets.

AnVil is based in Burlington, Massachusetts. For more information, visit www.anvilinfo.com, or call 1-781-272-1600. E-mail inquiries should be sent to: William Wiegler at wwiegler@anvilinfo.com.

Copyright (c) 2003 AnVil, Inc. All rights reserved.

back to top